Literature DB >> 15785381

Leukemia inhibitory factor is linked to regulatory transplantation tolerance.

Su M Metcalfe1, Tracy J Watson, Sandra Shurey, Elizabeth Adams, Colin J Green.   

Abstract

BACKGROUND: The specific regulation of allo-tolerance in vivo occurs within a complex microenvironment and involves co-operation between a small proportion of different cell types within the spleen or draining lymph node. By analyzing unmanipulated whole spleen cell populations we have aimed to mimic this in vivo situation to identify critical signaling molecules in regulatory allo-tolerance.
METHODS: We compared the kinetics of cytokine release and induction of signaling proteins in (BALB/c-tolerant)CBA, versus (BALB/c-rejected)CBA, spleen cells after challenge with BALB/c antigen.
RESULTS: The distinguishing features of allo-tolerance were Foxp3 protein expression, LIF release, and increased levels of STAT3. Comparison of isogenic clones of Tr1, Th1, and Th2 cells revealed that only the regulatory Tr1 cells are characterized by both LIF and IL10 release.
CONCLUSIONS: Overall, our findings demonstrate that allo-antigen driven signaling events can be detected within a whole spleen cell population and identify a role for LIF in the regulation of transplantation tolerance in vivo.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15785381     DOI: 10.1097/01.tp.0000149324.42994.38

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  16 in total

Review 1.  Micro and nanoparticle drug delivery systems for preventing allotransplant rejection.

Authors:  James D Fisher; Abhinav P Acharya; Steven R Little
Journal:  Clin Immunol       Date:  2015-05-01       Impact factor: 3.969

Review 2.  Harnessing the lymph node microenvironment.

Authors:  Natalie A O'Neill; Haleigh B Eppler; Christopher M Jewell; Jonathan S Bromberg
Journal:  Curr Opin Organ Transplant       Date:  2018-02       Impact factor: 2.640

Review 3.  Applied Bioengineering in Tissue Reconstruction, Replacement, and Regeneration.

Authors:  Juan M Colazo; Brian C Evans; Angel F Farinas; Salam Al-Kassis; Craig L Duvall; Wesley P Thayer
Journal:  Tissue Eng Part B Rev       Date:  2019-08       Impact factor: 6.389

4.  A LIF/Nanog axis is revealed in T lymphocytes that lack MARCH-7, a RINGv E3 ligase that regulates the LIF-receptor.

Authors:  Lorraine H Thompson; Roy A Whiston; Yerzhan Rakhimov; Cristian Taccioli; Chang-Gong Liu; Carlo Croce; Su M Metcalfe
Journal:  Cell Cycle       Date:  2010-10-04       Impact factor: 4.534

5.  Treg versus Th17 lymphocyte lineages are cross-regulated by LIF versus IL-6.

Authors:  Wenda Gao; Lorraine Thompson; Qiang Zhou; Prabhakar Putheti; Tarek M Fahmy; Terry B Strom; Su M Metcalfe
Journal:  Cell Cycle       Date:  2009-05-04       Impact factor: 4.534

Review 6.  Role of lymph node stroma and microenvironment in T cell tolerance.

Authors:  Vikas Saxena; Lushen Li; Christina Paluskievicz; Vivek Kasinath; Asher Bean; Reza Abdi; Christopher M Jewell; Jonathan S Bromberg
Journal:  Immunol Rev       Date:  2019-09-19       Impact factor: 12.988

7.  Modulation of CD4+ T lymphocyte lineage outcomes with targeted, nanoparticle-mediated cytokine delivery.

Authors:  Jason Park; Wenda Gao; Roy Whiston; Terry B Strom; Su Metcalfe; Tarek M Fahmy
Journal:  Mol Pharm       Date:  2010-12-08       Impact factor: 4.939

Review 8.  Biomaterial Strategies for Immunomodulation.

Authors:  Nathan A Hotaling; Li Tang; Darrell J Irvine; Julia E Babensee
Journal:  Annu Rev Biomed Eng       Date:  2015-09-29       Impact factor: 9.590

9.  Immuno-isolation of pancreatic islet allografts using pegylated nanotherapy leads to long-term normoglycemia in full MHC mismatch recipient mice.

Authors:  Huansheng Dong; Tarek M Fahmy; Su M Metcalfe; Steve L Morton; Xiao Dong; Luca Inverardi; David B Adams; Wenda Gao; Hongjun Wang
Journal:  PLoS One       Date:  2012-12-05       Impact factor: 3.240

10.  Leukemia Inhibitory Factor Protects Neurons from Ischemic Damage via Upregulation of Superoxide Dismutase 3.

Authors:  Stephanie M Davis; Lisa A Collier; Christopher C Leonardo; Hilary A Seifert; Craig T Ajmo; Keith R Pennypacker
Journal:  Mol Neurobiol       Date:  2016-01-09       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.